NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on an MRD-based protocol

Svaton, M; Skotnicova, A; Reznickova, L; Rennerova, A; Valova, T; Kotrova, M; van der Velden, VHJ; Brüggemann, M; Darzentas, N; Langerak, AW; Zuna, J; Stary, J; Trka, J; Fronkova, E

Fronkova, E (通讯作者),Charles Univ Prague, Fac Med 2, Dept Paediat Haematol & Oncol, CLIP Childhood Leukaemia Invest Prague, V Uvalu 84, Prague 15006, Czech Republic.;Fronkova, E (通讯作者),Univ Hosp Motol, V Uvalu 84, Prague 15006, Czech Republic.

BLOOD, 2023; 141 (5): 529